Impact Factor: 5.6     h-index: 28

A Molecular Docking Study: Benzoxazolone Derivatives against SARS-CoV-2 Omicron Subvariant EG.5.1
A Molecular Docking Study: Benzoxazolone Derivatives against SARS-CoV-2 Omicron Subvariant EG.5.1

Emine Erdag

Volume 7, Issue 11 , November 2023, , Pages 825-836

https://doi.org/10.48309/chemm.2023.423231.1736

Abstract
  In the ongoing COVID-19 pandemic, it is important to develop treatment strategies and new drug candidates that target the interactions between the receptor-binding domains (RBDs) of ...  Read More